The effects of oral administration of D-modafinil on male rat ejaculatory behavior

Journal of Sexual Medicine

Volumn 7, Issue 1 PART 1, 2010, Pages 70-78

  Marson, Lesley ^a   Yu, Guozhong ^a   Farber, Neal M ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NeuroHealing Pharmaceuticals   (United States)

Author keywords

Animal models for ejaculatory behavior; Intromission; Premature ejaculation; Sexual behavior

Indexed keywords

MODAFINIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COPULATION; DOSE RESPONSE; DRUG DOSE COMPARISON; EJACULATION; FEMALE; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

EID: 74049146657     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01509.x     Document Type: Article

References (59)

1. Waldinger MD, Schweitzer DH, Olivier B. On-demand SSRI treatment of premature ejaculation: Pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2005, 2:121-31.
2. Waldinger MD, Schweitzer DH. Retarded ejaculation in men: An overview of psychological and neurobiological insights. World J Urol 2005, 23:76-81.
3. Hartmann U, Waldinger MD. Ejaculatory disorders. World J Urol 2005, 23:67.
4. Waldinger MD. Premature ejaculation: Definition and drug treatment. Drugs 2007, 67:547-68.
5. McKenna KE, Marson L, Jordan D. Spinal and brainstem control of sexual function. Central control of autonomic function 1997, 151-87. In, ed., Amsterdam, The Netherlands, Hardwood Academic Publishers
6. Giuliano F, Clement P. Serotonin and premature ejaculation: From physiology to patient management. Eur Urol 2006, 50:454-66.
7. de Jong TR, Veening JG, Waldinger MD, Cools AR, Olivier B. Serotonin and the neurobiology of the ejaculatory threshold. Neurosci Biobehav Rev 2006, 30:893-907.
8. Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009, 55:957-67.
9. Duteil J, Rambert FA, Pessonnier J, Hermant JF, Gombert R, Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 1990, 180:49-58.
10. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006, 319:561-9.
11. Wisor JP, Eriksson KS. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 2005, 132:1027-34.
12. Wisor JP, Dement WC, Aimone L, Williams M, Bozyczko-Coyne D. Armodafinil, the R-enantiomer of modafinil: Wake-promoting effects and pharmacokinetic profile in the rat. Pharmacol Biochem Behav 2006, 85:492-9.
13. Beracochea D, Cagnard B, Celerier A, le Merrer J, Peres M, Pierard C. First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice. Neuroreport 2001, 12:375-8.
14. Beracochea D, Celerier A, Peres M, Pierard C. Enhancement of learning processes following an acute modafinil injection in mice. Pharmacol Biochem Behav 2003, 76:473-9.
15. Pierard C, Liscia P, Philippin JN, Mons N, Lafon T, Chauveau F, Van Beers P, Drouet I, Serra A, Jouanin JC, Beracochea D. Modafinil restores memory performance and neural activity impaired by sleep deprivation in mice. Pharmacol Biochem Behav 2007, 88:55-63.
16. Morgan RE, Crowley JM, Smith RH, LaRoche RB, Dopheide MM. Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats. Pharmacol Biochem Behav 2007, 86:531-41.
17. Ward CP, Harsh JR, York KM, Stewart KL, McCoy JG. Modafinil facilitates performance on a delayed nonmatching to position swim task in rats. Pharmacol Biochem Behav 2004, 78:735-41.
18. Randall DC, Shneerson JM, Plaha KK, File SE. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 2003, 18:163-73.
19. Waters KA, Burnham KE, O'Connor D, Dawson GR, Dias R. Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. J Psychopharmacol 2005, 19:149-58.
20. Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P. Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. J Clin Pharmacol 1999, 39:281-8.
21. Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC, Grebow PE. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999, 39:30-40.
22. Pattij T, Olivier B, Waldinger MD. Animal models of ejaculatory behavior. Curr Pharm Des 2005, 11:4069-77.
23. Olivier B, Chan JS, Pattij T, de Jong TR, Oosting RS, Veening JG, Waldinger MD. Psychopharmacology of male rat sexual behavior: Modeling human sexual dysfunctions? Int J Impot Res 2006, 18(1):S14-23. suppl
24. Giuliano F, Clement P. Physiology of ejaculation: Emphasis on serotonergic control. Eur Urol 2005, 48:408-17.
25. Sura A, Overstreet DH, Marson L. Selectively bred male rat lines differ in naive and experienced sexual behavior. Physiol Behav 2001, 72:13-20.
26. Looney C, Thor KB, Ricca D, Marson L. Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior. Pharmacol Biochem Behav 2005, 82:427-33.
27. de Jong TR, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: Comparison of fluvoxamine and paroxetine. Psychopharmacology (Berl) 2005, 179:509-15.
28. de Jong TR, Pattij T, Veening JG, Dederen PJ, Waldinger MD, Cools AR, Olivier B. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior. Neuroscience 2005, 134:1351-61.
29. Waldinger MD, van De Plas A, Pattij T, van Oorschot R, Coolen LM, Veening JG, Olivier B. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl) 2002, 160:283-9.
30. Mos J, Mollet I, Tolboom JT, Waldinger MD, Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol 1999, 9:123-35.
31. Clement P, Bernabe J, Gengo P, Denys P, Laurin M, Alexandre L, Giuliano F. Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine. Eur Urol 2007, 51:825-32.
32. Gengo P, Marson L, Gravitt K. Actions of dapoxetine on ejaculation and sexual behavior in rats. J Sex Med 2006, 3:200.
33. Lentz A, Gravitt K, Carson CC, Marson L. Acute and chronic dosing of Lepidium meyenii (Maca) on male rat sexual behavior. J Sex Med 2007, 4:332-9. discussion 339-40
34. Ratnasooriya WD, Fernando TS. Effect of black tea brew of Camellia sinensis on sexual competence of male rats. J Ethnopharmacol 2008, 118:373-7.
35. Yakubu MT, Afolayan AJ. Effect of aqueous extract of Bulbine natalensis (Baker) stem on the sexual behaviour of male rats. Int J Androl 2008, Aug 15 [Epub ahead of print] doi: 10.1111/j.1365-2605.2008.00910.x.
36. Clement P, Pozzato C, Heidbreder C, Alexandre L, Giuliano F, Melotto S. Delay of ejaculation induced by SB-277011, a selective dopamine d3 receptor antagonist, in the rat. J Sex Med 2009, 6:980-8.
37. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies. Arzneimittelforschung 1989, 39:1268-73.
38. Touret M, Sallanon-Moulin M, Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound: Comparative study with amphetamine in the rat. Neurosci Lett 1995, 189:43-6.
39. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000, 20:8620-8.
40. Randall DC, Fleck NL, Shneerson JM, File SE. The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav 2004, 77:547-55.
41. Ferraro L, Fuxe K, Tanganelli S, Fernandez M, Rambert FA, Antonelli T. Amplification of cortical serotonin release: A further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology 2000, 39:1974-83.
42. Ferraro L, Fuxe K, Tanganelli S, Tomasini MC, Rambert FA, Antonelli T. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression. J Neurosci Res 2002, 68:107-12.
43. Ferraro L, Fuxe K, Agnati L, Tanganelli S, Tomasini MC, Antonelli T. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat. Synapse 2005, 55:230-41.
44. Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA. Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. Neuropharmacology 2007, 52:626-33.
45. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 2008, 28:8462-9.
46. Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992, 591:319-26.
47. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98:437-51.
48. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA 2009, 301:1148-54.
49. Regenthal R, Koch H, Kohler C, Preiss R, Krugel U. Depression-like deficits in rats improved by subchronic modafinil. Psychopharmacology (Berl) 2009, 204:627-39.
50. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: Influences on male sexual behavior. Physiol Behav 2004, 83:291-307.
51. Dominguez JM, Hull EM. Dopamine, the medial preoptic area, and male sexual behavior. Physiol Behav 2005, 86:356-68.
52. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996, 93:14128-33.
53. Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998, 241:95-8.
54. Willie JT, Renthal W, Chemelli RM, Miller MS, Scammell TE, Yanagisawa M, Sinton CM. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience 2005, 130:983-95.
55. Fiocchi EM, Lin YG, Aimone L, Gruner JA, Flood DG. Armodafinil promotes wakefulness and activates Fos in rat brain. Pharmacol Biochem Behav 2009, 92:549-57.
56. Coolen LM, Peters HJ, Veening JG. Fos immunoreactivity in the rat brain following consummatory elements of sexual behavior: A sex comparison. Brain Res 1996, 738:67-82.
57. Greco B, Edwards DA, Michael RP, Zumpe D, Clancy AN. Colocalization of androgen receptors and mating-induced FOS immunoreactivity in neurons that project to the central tegmental field in male rats. J Comp Neurol 1999, 408:220-36.
58. Hamson DK, Watson NV. Regional brainstem expression of Fos associated with sexual behavior in male rats. Brain Res 2004, 1006:233-40.
59. Phillips-Farfan BV, Fernandez-Guasti A. c-Fos expression related to sexual satiety in the male rat forebrain. Physiol Behav 2007, 91:609-19.